Advancing surveillance of antimicrobial resistance: Summary of the 2015 CIDSC Report

Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
K AmaratungaAntimicrobial Resistance (AMR) Surveillance Task Group

Abstract

Antimicrobials are essential for the treatment and control of infectious diseases and therefore, the development and spread of antimicrobial resistance (AMR) is a global health concern. It is recognized that robust AMR surveillance is necessary; however, current gaps in national surveillance programs need to be addressed to enable better evidence-informed program and policy decisions. To describe how an AMR Surveillance Task Group prioritized national AMR surveillance data requirements for high priority AMR organisms for human health in Canada and made recommendations on addressing the current data gaps. The 2015 AMR Surveillance Task Group examined the data requirements for previously identified first priority organisms and assessed whether the current system met, partially met or did not meet these requirements. Information was summarized into synopsis tables and a ranking process was used to prioritize the data requirements and develop specific recommendations to address the gaps. First priority organisms identified for AMR surveillance are: Clostridium difficile, Extended-spectrum β-lactamase-producing organisms, Carbapenem-resistant organisms (Acinetobacter + Enterobacteriaceae species), Enterococcus species, Neisseria gon...Continue Reading

Citations

Jul 30, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Seungwon LeeElizabeth Henderson
Mar 23, 2021·Current Epidemiology Reports·Matthew M IppolitoJonathan J Juliano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
M EbrahimC Hyson
Canadian Journal of Microbiology
J M Blondeau, D Vaughan
Pathogens and Global Health
Francesca PrestinaciAnnalisa Pantosti
Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
J Spika, E W Rud
The New Zealand Medical Journal
Deborah A Williamson, Helen Heffernan
© 2022 Meta ULC. All rights reserved